Novel Therapies Symposium

The Novel Therapies Symposium showcases clinical trials on emerging compounds, including proof-of-concept and post-marketing studies, with a focus on data from human trials – particularly phase II and III. We aim to highlight studies which have not yet been published as journal articles.

Propose your new medication or medical device

Advances in medications and medical devices: application of new drugs and technology in clinical settings.

Building on last year’s expansion, we continue to welcome submissions featuring new medical devices, such as neurostimulation and other cutting‑edge technologies.

How to submit

If you are interested in presenting your new medication or device at the 39th ECNP Congress, please prepare the following details: 

  • A suggested speaker and back-up speaker (name, country, e-mail)
  • A presentation title (max. 20 words) 
  • A summary explaining the content of the presentation (max. 250 words) 
  • A short motivation: why is it important that these findings are shared?

Deadline

The deadline to submit a lecture proposal is 30 April 2026.

The form will open here on 19 February 2026. A 'Submit' button will appear then, so you can complete your submission.

Review

All submissions will be reviewed by the Scientific Programme Committee (SPC) for acceptance, the outcome of the review will be communicated before 18 June 2026.     

Further information

Selected speakers will receive:

  • Approximately 15 minutes to present their research
  • Reimbursement of travel and accommodation costs 

We accepted submissions from both academia and industry.